Back
Atara Biotherapeutics Vs. Perspective Therapeutics Industry Stock Comparison
Sell
43
ATRA
Atara Biotherapeutics
Last Price:
10.60
Seasonality Move:
16.06%
Sell
30
CATX
Perspective Therapeutics
Last Price:
2.99
Seasonality Move:
34.33%
Sell
43
Atara Biotherapeutics (ATRA)
is a Sell
Is Atara Biotherapeutics a Buy, Sell or Hold?
- The current Atara Biotherapeutics [ATRA] share price is $10.68. The Score for ATRA is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
- ATRA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
30
Perspective Therapeutics (CATX)
is a Sell
Is Perspective Therapeutics a Buy, Sell or Hold?
- The current Perspective Therapeutics [CATX] share price is $6.17. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ATRA Stock Price Chart
What is Atara Biotherapeutics's stock price today?
-
The Atara Biotherapeutics share price today is $10.68
The current trend is moderately bearish and ATRA is experiencing slight selling pressure.
CATX Stock Price Chart
What is Perspective Therapeutics's stock price today?
-
The Perspective Therapeutics share price today is $6.17
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing selling pressure, which indicates risk of future bearish movement.
ATRA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.77 | Buy |
| Relative Strength Index (14 RSI): | 51.56 | Buy |
| Chaikin Money Flow: | -14360 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (8.82 - 11.78) | Buy |
| Bollinger Bands (100): | (7.36 - 10.48) | Buy |
CATX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.47 | Sell |
| Relative Strength Index (14 RSI): | 14.63 | Sell |
| Chaikin Money Flow: | -723713 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (8.98 - 12.88) | Sell |
| Bollinger Bands (100): | (10.81 - 14.53) | Sell |
ATRA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 11.95 | Sell |
| 20-day SMA: | 10.59 | Buy |
| 50-day SMA: | 9.14 | Buy |
| 200-day SMA: | 12.56 | Sell |
| 8-day EMA: | 11.39 | Sell |
| 20-day EMA: | 10.77 | Sell |
| 50-day EMA: | 9.79 | Buy |
| 200-day EMA: | 14.79 | Sell |
CATX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 8.55 | Sell |
| 20-day SMA: | 10.54 | Sell |
| 50-day SMA: | 12.08 | Sell |
| 200-day SMA: | 12.78 | Sell |
| 8-day EMA: | 8.2 | Sell |
| 20-day EMA: | 9.96 | Sell |
| 50-day EMA: | 11.52 | Sell |
| 200-day EMA: | 11.52 | Sell |
Atara Biotherapeutics Earnings Growth & ATRA Earnings Dates
- Analysts estimate an earnings increase this quarter of $13.31 per share, a decrease next quarter of $0.00 per share, an increase this year of $56.86 per share, and a decrease next year of $2.21 per share.
Perspective Therapeutics Earnings Growth & CATX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.78 per share, and a decrease next year of $0.49 per share.
Atara Biotherapeutics Technical Analysis
| Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Perspective Therapeutics Technical Analysis
| Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||